Format

Send to

Choose Destination
Front Pharmacol. 2015 Oct 5;6:218. doi: 10.3389/fphar.2015.00218. eCollection 2015.

HDL particle number and size as predictors of cardiovascular disease.

Author information

1
National Institute for Health and Medical Research (INSERM), UMR-ICAN 1166, Pitié-Salpétrière University Hospital, University of Pierre and Marie Curie -Paris 6 Paris, France.

Abstract

Previous studies indicate that reduced concentrations of circulating high-density lipoprotein (HDL) particles can be superior to HDL-cholesterol (HDL-C) levels as a predictor of cardiovascular disease. Measurements of HDL particle numbers, therefore, bear a potential for the improved assessment of cardiovascular risk. Furthermore, such measurement can be relevant for the evaluation of novel therapeutic approaches targeting HDL. Modern in-depth analyses of HDL particle profile may further improve evaluation of cardiovascular risk. Although clinical relevance of circulating concentrations of HDL subpopulations to cardiovascular disease remains controversial, the negative relationship between the number of large HDL particles and cardiovascular disease suggests that assessment of HDL particle profile can be clinically useful. Reduced mean HDL size is equally associated with cardiovascular disease in large-scale clinical studies. Since HDL-C is primarily carried in the circulation by large, lipid-rich HDL particles, the inverse relationship between HDL size and cardiovascular risk can be secondary to those established for plasma levels of HDL particles, HDL-C, and large HDL. The epidemiological data thereby suggest that HDL particle number may represent a more relevant therapeutic target as compared to HDL-C.

KEYWORDS:

HDL cholesterol; atherosclerosis; cardiovascular disease; cardiovascular risk; circulating levels; high-density lipoprotein; large HDL; particle number; plasma concentrations

Supplemental Content

Full text links

Icon for Frontiers Media SA Icon for PubMed Central
Loading ...
Support Center